Phase Two Ventures

VC San Diego, United States · Founded 2023

Phase Two Ventures invests in early-stage life science tools, platform technologies, and computational biology to support the next generation of basic research, diagnostics, and therapeutics.

About Phase Two Ventures

Phase Two Ventures is a venture firm with website, LinkedIn and Crunchbase presence whose naming suggests a thesis focused on Series A or growth-stage ‘phase two’ investing rather than seed-first positioning. The source data carries no disclosed healthcare thesis, AI angle, geography or check size. Founders should treat Phase Two as a Series A or early growth participant whose value is most relevant after meaningful product-market fit and revenue traction is demonstrated. Plausible check sizes for a firm of this profile sit in the $1M to $5M range as a participant in Series A rounds, with limited capacity to lead competitive Series A deals at scale. For healthcare founders, Phase Two is most plausibly relevant if you are post-seed with proven commercial traction in digital health, healthcare IT, B2B SaaS targeting healthcare buyers, or AI-enabled clinical workflow software, and you are syndicating a Series A round. The firm is a poor fit for pre-revenue therapeutics, devices and diagnostics, and for very early seed companies still in product validation. Founders should not assume hospital network or payer access; healthcare-specific operating support is unverified. Entry is realistic via direct LinkedIn outreach to firm principals, ideally warmed by a Series A co-investor or portfolio founder, with a tight commercial story emphasizing ARR economics, retention and growth efficiency. In a first conversation, push for current fund size, lead capacity at Series A, average check, healthcare exposure in the existing portfolio, and named partner conviction before investing significant cycles.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Phase Two Ventures

Tools made by companies in Phase Two Ventures's portfolio that we cover in the directory.

Aqurio
Aqurio
Medical Phone & Communication
Aqurio offers an Agentic AI platform for healthcare operations, providing AI agents for automating scheduling, closing chronic disease care gaps, and managing patient outreach, particularly beneficial for endocrinology and metabolic health practices.

Portfolio companies in our directory

Other portfolio companies

Companies in Phase Two Ventures's portfolio not currently in our directory.

Team

José Morachis
Founder and Managing Partner
Will Alaynick
Founder and Managing Partner
Eddie Rodriguez
Venture Partner

Pitch / review this investor

Have you raised from Phase Two Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.